A detailed history of Armis Advisers, LLC transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Armis Advisers, LLC holds 42,795 shares of TLSA stock, worth $94,149. This represents 0.01% of its overall portfolio holdings.

Number of Shares
42,795
Previous 42,795 -0.0%
Holding current value
$94,149
Previous $58.2 Million 8.82%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 08, 2025

BUY
$0.63 - $1.69 $26,960 - $72,323
42,795 New
42,795 $58.2 Million

Others Institutions Holding TLSA

About Tiziana Life Sciences Ltd


  • Ticker TLSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,273,000
  • Market Cap $225M
  • Description
  • Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...
More about TLSA
Track This Portfolio

Track Armis Advisers, LLC Portfolio

Follow Armis Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armis Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armis Advisers, LLC with notifications on news.